According to a Danish cohort study involving premenopausal women diagnosed with non-metastatic breast cancer, carriers of the GSTP1 rs1138272 and CYP3A rs10273424 genetic variants exhibited elevated mortality rates. The gene discussed is CYP3A4; the disease is breast carcinoma.